Skip to main content
Mark Mirochnick, MD, Neonat/Perinatology, Boston, MA

MarkHMirochnickMD

Neonat/Perinatology • Boston, MA

Professor, Pediatrics, Boston University School of Medicine

Join to view full profile

Dr. Mirochnick is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Mirochnick's full profile

Already have an account?

  • Office

    840 Harrison Ave
    Menino 3
    Boston, MA 02118
    Phone+1 617-414-5471
    Fax+1 617-414-4358

Education & Training

  • University of Connecticut
    University of ConnecticutFellowship, Neonatal-Perinatal Medicine, 1984 - 1986
  • Boston Children’s Hospital/Boston Medical Center
    Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 1980 - 1983
  • University of Vermont College of Medicine
    University of Vermont College of MedicineClass of 1980

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1983 - 2025
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Neonatal-Perinatal Medicine

Clinical Trials

Publications & Presentations

PubMed

Grant Support

  • Safety Pharmacokinetics &Efficacy Of Artemether &Lumefantrine In Pregnant WomenNational Institute Of Allergy And Infectious Diseases2008
  • Pharmacokinetics Of Antiretroviral Drugs In Pregnant HIV Infected WomenNational Center For Research Resources2007
  • Antiretroviral Drugs During PREGNANCY, Substudy Of Pactg P1025National Center For Research Resources2007
  • Perinatal Core Protocol For HIV Infected Women (Pactg P1025, Version 20)National Center For Research Resources2006–2007
  • Antiretroviral Drugs During PREGNANCY, HIV Infected Women (Sub Of Pactg P1025)National Center For Research Resources2006
  • Antiretroviral Pharmacology/Lactating Mother/InfantsEunice Kennedy Shriver National Institute Of Child Health &Human Development2005–2006
  • Perinatal Core Protocol In HIV Infected Women (Pactg P1025, Version 20)National Center For Research Resources2005
  • Antiretroviral Drugs During Pregnancy In HIV Positive FemalesNational Center For Research Resources2005
  • Perinatal Core Protocol (Pactg P1025, Version 2.0)National Center For Research Resources2004
  • ACTG 316, V 1--Nevirapine Versus Nevirapine Placebo In Pregnant HIV WomenNational Center For Research Resources1999–2001
  • ACTG 353, V 2--Nelfinavir Coadministered W/ Zidovudine &LamivudineNational Center For Research Resources1999–2000
  • Recombinant HIV 1 Envelope Antigen In Children Born To HIV Infected MothersNational Center For Research Resources1997–1999
  • Determinations Of Cannabinoids In MeconiumNational Center For Research Resources1998
  • Hivig In The Prevention Of Maternal Fetal Transmission Of HIVNational Center For Research Resources1997
  • Hivig In The Prevention Of Maternal-Fetal Transmission Of HIVNational Center For Research Resources1996
  • Pharmacokinetics Of Dapsone In ChildrenNational Center For Research Resources1992–1993
  • Intravenous AZT In Infants With HIVNational Center For Research Resources1991

Dr. Mark Mirochnick, Dr. Mark Mirochnick, MD, Dr. M Mirochnick, Dr. Mark H Mirochnick